Cross communication of diet-microbiome-immune interactions in cancer immunotherapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36384089.
- Also identified by DOI 10.1016/j.xcrm.2022.100806 and PMC identifier 9729813.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Simpson et al. have highlighted a diet-driven microbiome community, which paves the way for landmark therapeutic avenues for facilitating efficacy and minimizing immune-related adverse events during neoadjuvant immune checkpoint inhibitor treatment in melanoma patients. This innovative attempt inspires application of the diet-microbiome-immune interaction axis to maximize clinical benefits.
Medical subject headings
- Diet
- Microbiota